| Collaborations |
|
Celera Diagnostics
Long-term strategic alliance to develop, manufacture and market a broad range of in vitro molecular diagnostic products for disease detection, disease progression monitoring and therapy selection.
|
|
Incyte Corporation
|
|
Genetronics, Inc.
On November 26, 1997, Genetronics announced a supply agreement with Abbott Laboratories allowing Genetronics to purchase the approved anti-cancer drug bleomycin for use with Genetronics MedPulser® drug delivery system in treatment of cancer.
|
|
Metabolex, Inc.
|
|
Celera Corporation
Broad program to discover, develop and commercialize therapies for the treatment of cancer, including therapeutic antibodies and small molecules.
|
|
Rosetta Inpharmatics, Inc.
Investigation on molecular basis of hepatoxicity
|
|
Medarex, Inc.
|
|
MedImmune
|